-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - We do not anticipate excluding
observational studies assessing harms. … For all Key Questions, we excluded uncontrolled
observational studies, case series, and case reports … Peer reviewers do not
participate in writing or editing of the final report or other products. … Protocol: mixed-methods study of how
implementation of US state medical
cannabis laws affects treatment … studies, registries and case
reports.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-october-2018
October 23, 2018 - staff reported no adverse events; however, it is not clear whether adverse events were prespecified or how … How well do interventions reduce exposure to IPV, physical or mental morbidity, or mortality among screen-detected … RCTs (n = 1031) reported that no harms were associated with the intervention but did not comment on how … The opinions expressed in this document are those of the authors and do not reflect the official position … Domestic violence: how to screen & intervene. RN . 2000;63(12):52-56.
48.
-
meps.ahrq.gov/data_files/publications/mr3/mr3.pdf
September 01, 1998 - , with information on how to obtain these
resources. … (For operational details
on how this was accomplished, see information in this
report on the Round 1 … A
fictitious example of how a Place Roster might look on
the interviewer’s laptop at the end of the Round … DO NEXT. … As a result,
interviewers do not have to key the name, form, and
strength of drugs on the preloaded list
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - and
conclusions in this document are those of the authors, who are responsible for its content, and do … However, they believe that questions remain about how much additional benefit
this intervention would … However, a couple of
experts raised questions about the role of the patient’s physician and how he … However, they believe that questions remain about how much additional benefit this
intervention offers … Experts were divided about how this intervention would affect patient management and
treatment models
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - Additionally, many individuals clinically
diagnosed with CATD do not meet
neuropathologic (gold standard … Therefore, we also need better
understanding of how accurate pre-
mortem brain imaging and cerebrospinal … Research should better clarify
how biomarker accuracy varies as a function of the
time between biomarker … collection and autopsy,
to inform how changes in biomarkers and brain
neuropathology over time affect … Studies should report information
about participant clinical diagnosis to make it clear
how often clinical
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs021769-anderson-final-report-2016.pdf
January 01, 2016 - supported by grant
number R21 HS21769-02 and its contents are solely the responsibility of the authors and do … four days prior to each scheduled clinical
visit; and (3) monthly, if a patient did not have a clinical … They were also asked if
they had filled their antidepressant prescription, and if so, how many doses … interact with the participating practices on a regular basis and do in-person
recruitment and consenting … their antidepressant and if so, how
many doses they had missed in the past week.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/gJQj_6nEHZ7XAhYPfhVR33
January 01, 2016 - These average estimates do not reflect greater ex-
tremes seen among outlier radiologists. … As a result, across
studies a sizeable 13% to 19% of women (13–19) were
reclassified from “nondense” … Moving from a “dense” to a “non-
dense” breast categorization may result in different
mandated communications … Disclosures can also be viewed
at www.acponline.org/authors/icmje/ConflictOfInterestForms
.do? … negative
screening mammogram in women found to have dense breasts, and how do these performance
-
digital.ahrq.gov/sites/default/files/docs/citation/state-regional-demonstration-hit-in-final-report.pdf
July 01, 2015 - If So, How? … If So, How? … If So, How? … If So, How? … If So, How?
-
hcup-us.ahrq.gov/reports/statbriefs/sb27.jsp
March 01, 2007 - Login
Do Your own analysis
Explore Expert Research & Limited … Symptoms of a TBI can range from mild to severe, depending on the extent of damage to the brain. … According to the Centers for Disease Control and Prevention (CDC), TBIs contribute to a substantial number … We also invite you to tell us how you are using this Statistical Brief and other HCUP data and tools, … and to share suggestions on how HCUP products might be enhanced to further meet your needs.
-
digital.ahrq.gov/sites/default/files/docs/page/final-hit-enabled-quality-measurement-snapshot.pdf
July 01, 2012 - • How to Move to Patient-Centricity in a Fragmented Health Delivery System – Although there is consensus … Benin AL, Fenick A, Herrin J, et al.. How good are
the data? … It
measures what patients are able to do and how they feel by asking
questions. … • How do they hinder
progress related to quality
measurement enabled by
health IT? … • How do stakeholders
address known
gaps/problem areas?
-
digital.ahrq.gov/sites/default/files/docs/publication/final-hit-enabled-quality-measurement-snapshot.pdf
July 01, 2012 - • How to Move to Patient-Centricity in a Fragmented Health Delivery System – Although there is consensus … Benin AL, Fenick A, Herrin J, et al.. How good are
the data? … It
measures what patients are able to do and how they feel by asking
questions. … • How do they hinder
progress related to quality
measurement enabled by
health IT? … • How do stakeholders
address known
gaps/problem areas?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
March 01, 2009 - PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF
The DEcIDE (Developing Evidence to Inform … document are those of the authors, who are responsible for its
contents; the findings and conclusions do … To ensure a uniform 1-year eligibility period prior to filling the index APM
prescription, all study … CV or OOH CV deaths by conventional APM
vs. atypical APM use in patients with dementia (Table 4) do … How much are atypical antipsychotic agents
being used, and do they reach the populations
who need
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.jsp
January 01, 2005 - For more information on how hospitals in the data set were mapped to hospitals as defined by the AHA, … Contents
HOW TO USE THE NIS
This section provides a brief synopsis of special considerations when … Some states do not require hospitals to report E codes in the range E870-E879 - "misadventures to patients … This site includes links to information on how to purchase and understand the HCUP databases, as well … Topics range from how to use the NIS for reporting trends, how to properly calculate variance estimates
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-screening-older-adults
May 24, 2022 - How to implement this recommendation? … Clinicians should use their clinical judgement to determine how to evaluate patients who have symptoms … assessment tools and screening interventions that include higher-risk groups, as well as more research on how … Any adaptations of these electronic documents and resources must include a disclaimer to this effect. … Eye care in the United States: do we deliver to high-risk people who can benefit most from it?
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
August 23, 2022 - without a history of known CVD and who do not have signs and symptoms of CVD. … These recommendations do not apply to adults with a low-density lipoprotein cholesterol (LDL-C) level … The USPSTF also recommended that clinicians may choose to offer a low- to moderate-dose statin to adults … No trials reported how benefits of statin therapy vary according to socioeconomic characteristics. 13 … In addition, the USPSTF wants to clarify that these recommendations do not pertain to adults with familial
-
www.ahrq.gov/sites/default/files/2024-01/dresselhaus-report.pdf
January 01, 2024 - Consenting subjects agreed to carry a palm handheld unit for a 1-week period. … Subjects were
prompted by a handheld-generated audible alarm to initiate a survey. … However, they do permit some level of interpretive
analysis, even with incomplete error data points. … We hope that an improved understanding
of how these factors are influenced by workplace activity patterns … , as well as how psychosocial
characteristics affect medication error events, can be used in future
-
hcup-us.ahrq.gov/reports/methods/2009_02.pdf
January 01, 2009 - interest and a denominator
count of the population (within a hospital or geographic area) to which … Many hospitals do not code race and ethnicity
completely. … know if and how quality of care varies for these different
populations. … This document describes how state-level QIs by race/ethnicity and community
income quartile were generated … We do not employ finite
population correction factors in estimating standard errors.
-
hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2019.jsp
January 01, 2019 - This tutorial also describes how to verify that the data have loaded correctly. … Return to Introduction
HOW TO USE THE NEDS FOR DATA ANALYSIS
This section provides a brief … It may be useful to compare diagnosis-specific ED visits that do not result in hospitalization to those … Some States do not require hospitals to report codes for "misadventures to patients during surgical and … the NEDS to produce data elements not available for a certain data year may do so by downloading the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - how the new
evidence impacts findings of the 2020 report. … How does effectiveness or comparative effectiveness
vary depending on: (1) the specific type or cause … How do harms vary depending on: (1) the specific type or
cause of pain, (2) patient demographics, (3 … document are those of the authors, who are responsible for its contents; the findings
and conclusions do … How do harms vary depending on: (1) the specific type or cause of
pain, (2) patient demographics, (3
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
November 01, 2012 - ,
the review also evaluates how comparative effectiveness
varies depending on HCV genotype, viral load … How does the comparative effectiveness of antiviral
treatment for health outcomes vary according to … How does the comparative effectiveness of antiviral
treatment for intermediate outcomes vary according … Do these harms differ according to patient subgroup
characteristics, including HCV genotype, age, race … Low
Key Question 3b
Do these harms
differ according to
patient subgroup
characteristics?